Back to search
FDAFDA · Food and drugs·Recall number Z-2171-2013

ADVIA Centaur Folate (500 tests), REF SMN 10331250, Cat No. 00203473 In vitro diagnostic use in the quantitative determination of folate in serum or red blood cells.

Published September 18, 2013 · Recall initiated: July 25, 2013

Summary

FDA records medical device Class II recall Z-2171-2013, published September 18, 2013 and initiated July 25, 2013. Recalling firm: Siemens Healthcare Diagnostics, Inc; Status: Terminated; Reported quantity: 488; Lot: 22298218. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Calibration failures and/or significant negative shifts in quality control (QC) and patient results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc
Distributor
Worldwide Distribution - USA including AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA,MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV, and WY. Internationally to Canada and Mexico.
Lot
22298218
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ADVIA Centaur Folate (500 tests), REF SMN 10331250, Cat No. 00203473 In vitro diagnostic use in the quantitative determination of folate in serum or red blood cells. recalled?

Yes. FDA published recall Z-2171-2013 on September 18, 2013. Reported hazard: Calibration failures and/or significant negative shifts in quality control (QC) and patient results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter